The UK's burgeoning consciousness-expanding space is seeing a remarkable shift, moving far beyond the traditional focus on Lysergic Acid Diethylamide and Psilocybin. Interest in powerful substances like Dimethyltryptamine is growing, coupled with the emergence of novel cannabinoids, particularly CBG and other cannabinoids, which present different t